glp 1 efficacy comparison Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis GLP-1 receptor agonists in the

Although first-generation basal analogues and NPH insulin are frequently administered once daily, greater flexibility and better coverage of basal insulin needs may be achieved by administering them twice daily

A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers

One hundred seventeen adverse events occurred in 464 patients (25.2%) treated with at least one dose of N -acetylcysteine, and 98 adverse events occurred in 464 patients (21.1%) treated with at least one dose of placebo ( P = 0.16)

Future studies may consider extending the trial period to more fully evaluate the long-term effects of BCAA supplementation in lactating mares and provide a more comprehensive scientific basis for optimizing the nutritional management of Yili horses